Israel Biotech Fund GP Partners II, L.P. insider trades: Ayala Pharmaceuticals (ADXS) SEC Form 4 filings
Companies
Where Israel Biotech Fund GP Partners II, L.P. reports to the SEC
About Israel Biotech Fund GP Partners II, L.P.'s insider trades
Israel Biotech Fund GP Partners II, L.P. is a director at Ayala Pharmaceuticals (ADXS). It has not reported an open-market purchase or sale.
Its filings also include option exercises (2 filings), shares withheld for taxes (1 filing), other transactions (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every ADXS insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.